Cargando…
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
CDKN1A (p21) and CDKN2A (p16) inhibit CDK4/6, initiating senescence. According to our view on senescence, the role of p21 and p16 is to cause cell cycle arrest, whereas MTOR (mechanistic target of rapamycin) drives geroconversion to senescence. Recently we demonstrated that one of the markers of p21...
Autores principales: | Leontieva, Olga V, Blagosklonny, Mikhail V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875680/ https://www.ncbi.nlm.nih.gov/pubmed/23974099 http://dx.doi.org/10.4161/cc.26130 |
Ejemplares similares
-
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
por: Leontieva, Olga V., et al.
Publicado: (2014) -
Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
S6K in geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
por: Leontieva, Olga V., et al.
Publicado: (2015) -
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
por: Leontieva, Olga V., et al.
Publicado: (2010)